Published in Thorax on August 01, 1999
Prevalence and correlates of airflow obstruction in ∼317,000 never-smokers in China. Eur Respir J (2014) 3.89
Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health (2010) 1.52
Incidence of airflow limitation in subjects 65-100 years of age. Eur Respir J (2015) 1.39
Asthma and poverty. Thorax (2000) 1.38
Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health (2011) 1.24
Retrospective analysis of lung function abnormalities of Bhopal gas tragedy affected population. Indian J Med Res (2012) 1.19
Chronic obstructive pulmonary disease. BMJ (2003) 1.17
Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.17
Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract (2009) 1.04
Family history is a risk factor for COPD. Chest (2011) 0.96
Understanding patient participation behaviour in studies of COPD support programmes such as pulmonary rehabilitation and self-management: a qualitative synthesis with application of theory. NPJ Prim Care Respir Med (2015) 0.88
Socio-economic status and overall and cause-specific mortality in Sweden. BMC Public Health (2008) 0.87
Diet and airway obstruction: a cross sectional study from the second Korean National Health and Nutrition Examination Survey. Korean J Intern Med (2010) 0.86
Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis (2015) 0.85
Socioeconomic status is positively associated with percent emphysema on CT scan: The MESA lung study. Acad Radiol (2011) 0.81
Exposure to traffic and lung function in adults: a general population cohort study. BMJ Open (2015) 0.80
The prevalence of cardiopulmonary symptoms among Chinese older adults in the Greater Chicago area. J Gerontol A Biol Sci Med Sci (2014) 0.78
Effects of Air Pollution on Hospital Emergency Room Visits for Respiratory Diseases: Urban-Suburban Differences in Eastern China. Int J Environ Res Public Health (2016) 0.77
Warm homes for older people: aims and methods of a randomised community-based trial for people with COPD. BMC Public Health (2013) 0.76
Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda. NPJ Prim Care Respir Med (2016) 0.75
Socioeconomic status affects pulmonary hypertension disease severity at time of first evaluation. Pulm Circ (2016) 0.75
Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med (2016) 0.75
Investigating trends in asthma and COPD through multiple data sources: A small area study. Spat Spatiotemporal Epidemiol (2016) 0.75
Chronic disease, risk factors and disability in adults aged 50 and above living with and without HIV: findings from the Wellbeing of Older People Study in Uganda. Glob Health Action (2016) 0.75
Parental education and lung function of children in the PATY study. Eur J Epidemiol (2010) 0.75
The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa. Malawi Med J (2017) 0.75
Understanding the factors affecting self-management of COPD from the perspectives of healthcare practitioners: a qualitative study. NPJ Prim Care Respir Med (2017) 0.75
Different types of housing and respiratory health outcomes. Prev Med Rep (2017) 0.75
Inequalities in death--specific explanations of a general pattern? Lancet (1984) 13.99
Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation (1993) 11.57
Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet (1997) 11.25
Mortality decline and widening social inequalities. Lancet (1986) 10.56
Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ (1996) 6.25
Infant admissions to hospital and maternal smoking. Lancet (1974) 5.49
Childhood respiratory infection and adult chronic bronchitis in England and Wales. Br Med J (Clin Res Ed) (1986) 5.10
Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ (1991) 4.87
Mortality associated with moderate intakes of wine, beer, or spirits. BMJ (1995) 4.46
Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) (1982) 4.36
Do socioeconomic differences in mortality persist after retirement? 25 year follow up of civil servants from the first Whitehall study. BMJ (1996) 4.23
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Social inequalities in health: next questions and converging evidence. Soc Sci Med (1997) 3.55
Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv (1996) 3.19
The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis (1992) 3.01
Damp housing and childhood asthma: validation of reporting of symptoms. BMJ (1988) 2.72
Respiratory disease rates and pulmonary function in children associated with NO2 exposure. Am Rev Respir Dis (1980) 2.63
Home dampness and respiratory morbidity in children. Am Rev Respir Dis (1989) 2.59
Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. Br Med J (Clin Res Ed) (1987) 2.54
Review of the evidence on fetal and early childhood antecedents of adult chronic disease. Epidemiol Rev (1996) 2.45
Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ (1993) 2.44
Why are socioeconomic mortality differences smaller among women than among men? Soc Sci Med (1994) 2.41
Relation of fetal growth to adult lung function in south India. Thorax (1997) 2.40
Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J (1978) 2.35
Whither studies on the socioeconomic foundations of population health? Am J Public Health (1997) 2.32
Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med (1996) 2.31
Lung function in children of low birth weight. Arch Dis Child (1989) 2.29
Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control (1998) 2.13
Respiratory symptoms related to smoking habits of family adults. Chest (1976) 2.10
Predictors of smoking cessation: the Framingham Study. Am J Epidemiol (1992) 2.09
Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax (1997) 2.04
Is low birth weight a risk factor for asthma during adolescence? Arch Dis Child (1991) 2.02
Comparing inequalities in women's and men's health: Britain in the 1990s. Soc Sci Med (1997) 1.89
The relation between respiratory illness in primary schoolchildren and the use of gas for cooking--I. Results from a national survey. Int J Epidemiol (1979) 1.84
Dietary factors and their relation to respiratory symptoms. The Second National Health and Nutrition Examination Survey. Am J Epidemiol (1990) 1.84
Epidemiology of chronic mucus hypersecretion and obstructive airways disease. Epidemiol Rev (1979) 1.71
Why is chest disease so common in South Wales? Smoking, social class, and lung function: a survey of elderly men in two areas. J Epidemiol Community Health (1987) 1.62
Fish consumption may limit the damage of smoking on the lung. Am J Respir Crit Care Med (1994) 1.61
Respiratory symptoms in children of low birth weight. Arch Dis Child (1989) 1.60
Ventilatory function and winter fresh fruit consumption in a random sample of British adults. Thorax (1991) 1.59
Respiratory effects on household exposures to tobacco smoke and gas cooking. Am Rev Respir Dis (1981) 1.58
Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.54
Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol (1977) 1.50
Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr (1994) 1.40
Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. Am J Epidemiol (1993) 1.36
Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1994) 1.36
Damp housing and adult respiratory symptoms. Allergy (1992) 1.34
Relationship of parental smoking to wheezing and nonwheezing lower respiratory tract illnesses in infancy. Group Health Medical Associates. J Pediatr (1991) 1.33
The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med (1994) 1.29
Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol (1995) 1.28
Respiratory illness in households using gas and electricity for cooking. I. Survey of incidence. Environ Res (1979) 1.28
The relation of respiratory symptoms and ventilatory function to moderate occupational exposure in a general population. Results from the French PAARC study of 16,000 adults. Int J Epidemiol (1988) 1.27
Longitudinal effects of passive smoking on pulmonary function in New Zealand children. Am Rev Respir Dis (1992) 1.23
Smoking, socioeconomic status, and chronic respiratory disease. Am Rev Respir Dis (1977) 1.23
General explanations for social inequalities in health. IARC Sci Publ (1997) 1.21
Maternal age as a risk factor for wheezing lower respiratory illnesses in the first year of life. Am J Epidemiol (1992) 1.20
Effects of starvation on lung mechanics and biochemistry in young and old rats. J Appl Physiol (1985) (1985) 1.18
The foetal and infant origins of inequalities in health in Britain. J Public Health Med (1991) 1.17
Pulmonary follow-up of moderately low birth weight infants with and without respiratory distress syndrome. J Pediatr (1987) 1.17
Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med (1995) 1.14
The relation between respiratory illness in primary schoolchildren and the use of gas for cooking--III. Nitrogen dioxide, respiratory illness and lung infection. Int J Epidemiol (1979) 1.12
Pulmonary function is influenced by heavy alcohol consumption. Am Rev Respir Dis (1988) 1.08
Housing in early life and later mortality. J Epidemiol Community Health (1993) 1.07
Respiratory illness in households using gas and electricity for cooking. II. Symptoms and objective findings. Environ Res (1979) 1.02
Socioeconomic status and lung function among primary school children in Canada. Am J Respir Crit Care Med (1996) 1.02
The effects of intermittent starvation on lung development in suckling rats. Am J Pathol (1984) 1.01
Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol (1999) 0.98
Connective tissue, mechanical, and morphometric changes in the lungs of weanling rats fed a low protein diet. Pediatr Pulmonol (1989) 0.97
Prematurity is associated with abnormal airway function in childhood. Pediatr Pulmonol (1989) 0.96
Early lung growth and chronic airflow obstruction. Thorax (1994) 0.95
Effect of maternal malnutrition on surface activity of fetal lungs in rats. J Appl Physiol (1975) 0.94
Social class and cardiovascular risk factors in Danish men. Scand J Soc Med (1991) 0.94
Effects of home environment on respiratory symptoms and lung function in a general population sample in north Italy. Eur Respir J (1991) 0.88
Does dietary vitamin A protect against airway obstruction? The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Respir Crit Care Med (1994) 0.87
Lung mechanics, cellularity, and surfactant after prenatal starvation in guinea pigs. J Appl Physiol (1985) (1986) 0.87
The relationship of childhood respiratory infection to growth and decline in lung function. Am J Respir Crit Care Med (1996) 0.86
Effects of protein deprivation from the neonatal period on lung collagen and elastin in the rat. Pediatr Res (1989) 0.82
Associations between housing conditions, smoking habits and ventilatory lung function in men with clean jobs. Scand J Respir Dis (1978) 0.81
Longitudinal analysis of the effects of acute lower respiratory illnesses on pulmonary function in an adult population. Am J Epidemiol (1990) 0.81
A longitudinal study of risk factors in asthma and chronic bronchitis in childhood. Eur J Epidemiol (1990) 0.80
Social differences in health in an affluent Danish county. Scand J Soc Med (1998) 0.80
Natural immunity to dust mites in adults with chronic asthma. I. Mite-specific serum IgG and IgE. Am Rev Respir Dis (1986) 0.78
The relationship of socio-environmental factors to the prevalence of obstructive lung diseases and other chronic conditions. J Chronic Dis (1977) 0.77
Quantitative changes in DNA, RNA, and protein content of the various organs of the young of undernourished female rats. J Nutr (1974) 0.77
The effect of acute broncho-pulmonary infections on the FEV1 change in 13-year follow-up. The Cracow Study. Eur J Epidemiol (1990) 0.77
Chronic respiratory disease among nonsmokers in Hagerstown, Maryland. 3. Social class and chronic respiratory disease. Environ Res (1971) 0.76
Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 4.74
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Developing COPD: a 25 year follow up study of the general population. Thorax (2006) 3.72
Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ (1998) 3.45
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J (2008) 3.36
Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J (1997) 3.29
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J (2002) 3.22
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Epidemiology of chronic obstructive pulmonary disease. Eur Respir J (2001) 2.43
Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health (2003) 2.13
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J (2009) 2.11
COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J (2008) 2.06
Recommendations for epidemiological studies on COPD. Eur Respir J (2011) 1.84
Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health (1998) 1.80
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.78
The natural history of chronic obstructive pulmonary disease. Eur Respir J (2006) 1.66
Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax (1997) 1.62
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J (2002) 1.60
Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax (2002) 1.59
Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J (1999) 1.56
Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J (1995) 1.52
Mortality in women and men in relation to smoking. Int J Epidemiol (1998) 1.52
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J (2011) 1.47
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
Potential misclassification of causes of death from COPD. Eur Respir J (2006) 1.42
Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax (2008) 1.34
Social position and mortality from respiratory diseases in males and females. Eur Respir J (2003) 1.26
Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol (2005) 1.24
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J (2010) 1.23
Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med (2008) 1.17
Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology (1998) 1.15
Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet (1996) 1.14
Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers. Prev Med (2001) 1.12
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J (2005) 1.10
Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax (2006) 1.10
The International Journal of Tuberculosis and Lung Disease--a home for respiratory epidemiology. Int J Tuberc Lung Dis (1998) 1.08
Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.06
Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J (1995) 1.05
Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J (2009) 1.05
Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J (1993) 1.04
Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.04
Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax (2001) 1.00
Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens (1997) 0.98
Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem (2001) 0.97
Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness? Eur Respir J (2005) 0.97
Increase in prevalence and severity of asthma in young adults in Copenhagen. Thorax (2000) 0.97
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. J Epidemiol Community Health (1999) 0.94
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J Suppl (2003) 0.94
A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Copenhagen Center for Prospective Population Studies. Eur J Epidemiol (1998) 0.93
Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens (1995) 0.91
Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax (2009) 0.91
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J (2009) 0.91
The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens (2011) 0.89
Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest (1995) 0.88
Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J (2001) 0.85
Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J Med Genet (2006) 0.83
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.83
Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J (2009) 0.83
Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med (2014) 0.82
Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir Med (1997) 0.81
Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene. Thorax (2006) 0.81
CD8 chemokine receptors in chronic obstructive pulmonary disease. Clin Exp Immunol (2008) 0.80
Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun (2007) 0.80
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med (1999) 0.80
Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J (2007) 0.80
Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark. J Epidemiol Community Health (1997) 0.79
The pathophysiological role of mucus production in inflammatory airway diseases. Respir Med (1995) 0.79
Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital. Dan Med Bull (2001) 0.78
Outcomes in elderly Danish citizens admitted with community-acquired pneumonia. Regional differencties, in a public healthcare system. Respir Med (2012) 0.78
COPD in the ECRHS. Thorax (2004) 0.78
Value of Tru-cut lung biopsy in focal and diffuse lung disease. Thorax (1988) 0.78
Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. Chest (1997) 0.77
GOLD and the fixed ratio. Eur Respir J (2011) 0.77
Lung function decline in COPD trials. Eur Respir J (2009) 0.77
Bronchodilator and corticosteroid reversibility in ambulatory patients with airways obstruction. Dan Med Bull (1991) 0.77
[Chronic expectoration and risk of death in chronic obstructive lung disease]. Ugeskr Laeger (1996) 0.76
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J (2004) 0.75
Statistical analysis of COPD exacerbations. Eur Respir J (2008) 0.75
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax (2008) 0.75
Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Eur Respir J (2000) 0.75
Another piece of the inhaled corticosteroids-in-COPD puzzle. Am J Respir Crit Care Med (2001) 0.75
Is low intensity vibration harmful to the digits? Br J Ind Med (1985) 0.75
[Prevalence of asthma among young adults in Copenhagen]. Ugeskr Laeger (2001) 0.75
Has risk associated with smoking increased? Results from the Copenhagen Center for Prospective Population Studies. Int J Epidemiol (1997) 0.75
Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection. Clin Infect Dis (1997) 0.75
[Asthma and chronic obstructive lung disease. Prevention and treatment]. Ugeskr Laeger (2000) 0.75
[Global strategy when it comes to chronic obstructive lung disease]. Ugeskr Laeger (2001) 0.75
[Risk factors of death and hospitalization due to pneumonia. Results from the Osterbro study]. Ugeskr Laeger (1997) 0.75
[The course of pulmonary function in adults with asthma. The Osterbro study]. Ugeskr Laeger (2000) 0.75
[Are obesity and overweight risk factors of asthma?]. Ugeskr Laeger (2001) 0.75
[Smoking and life expectancy among Danish men and women]. Ugeskr Laeger (1999) 0.75
[Diagnosis of pneumonia in artificially ventilated patients]. Ugeskr Laeger (1996) 0.75
[Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases]. Ugeskr Laeger (2000) 0.75
A sensitivity analysis of secular trends in risk factors and mortality based on cohort studies. Epidemiology (1999) 0.75
[Mortality in adults with asthma. Results from the Osterbro study]. Ugeskr Laeger (1997) 0.75
[Isolated systolic hypertension: a significant risk factor of cerebral apoplexy and acute myocardial infarction. A prospective population based study]. Ugeskr Laeger (1996) 0.75
[Prognostic value of interleukin-8 in AIDS-related Pneumocystis carinii pneumonia]. Ugeskr Laeger (1996) 0.75